Fcγ receptor (FcγR) signalling in monocyte derived macrophages from persistent lymphocytic leukaemia (CLL) sufferers is poorly understood. This signalling pathway is the important thing determinant of the flexibility of the macrophages to reply to therapeutic antibodies in present scientific use for CLL. Muted FcγR signalling exercise accompanies illness development and ends in resistance to therapeutic […]
